AL-LAD (6-Allyl-6-nor-LSD)
A lysergamide similar to LSD but with a shorter duration and reportedly fewer anxious "head" effects, making it a popular research analog.
How it works
Activates serotonin 5-HT2A receptors, like LSD.
Key facts
- Molecular weight: 349.47 g/mol
- Half-life: ~3-4 hours
- Bioavailability: Oral
- Storage: Research/reference only.
Dosing overview
- Typical dose: Varies by individual and setting
- Frequency: Occasional
- Duration: Acute effects last 6-8 hours
- Route: Oral
Protocol notes
- Taken orally on blotter; shorter than LSD (6-8 hours) so easier to fit in a day.
- Reported to be more visual and less anxious than LSD.
Reported benefits
- Shorter than LSD
- Reportedly less anxious
- Strong visual component
- Lysergamide research compound
Possible side effects
- Anxiety
- Raised heart rate
- Visual distortions
- Limited human data
Community reviews of AL-LAD
- dad_talia rated it 5/5 - way less anxiety than typical lysergamides: im usually way too anxious for these, but AL-LAD actually let me relax. it seemed to clear my head without the panic, which was huge for my mood. it could just be my own experience, but imo this is the only one that doesnt make me feel on edge.
- grinder_reese rated it 4/5 - Clearer focus on lesson planning after a short AL‑LAD trip: After a single 70 µg AL‑LAD session I felt my mind stayed unusually organized for the next couple days, so writing lesson plans felt less like a chore and more like a flow. It wasn’t a permanent boost, but the temporary clarity was real enough to notice.
- earlyderek rated it 4/5 - Less anxious LSD‑like trip helped me focus after work: I tried AL‑LAD once a month for six weeks and the biggest thing I noticed was a calmer mind during the visual phase, which let me unwind after my data‑science job without the usual nervous edge, though the duration was still a bit long for me.
Compare AL-LAD
Research and educational reference only. Not medical advice.